China's SFDA Urges Drug Firms Do More Research On Adverse Reactions
This article was originally published in PharmAsia News
Executive Summary
China's State FDA is urging drug makers to do more and better research into their anti-infection drugs that cause adverse reactions, an issue that has become a growing problem in China.